Home | Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors.
Published clinical_trials Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. has only one revision
RevisionStatus
Saved 18/06/2024 - 11:15am by Gladys

Numero de Registro de Autorizacion de uso de emergencia ; AUE 02/2020 23.021.20B

current revision (published)
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.